• 5 min read
• Published on 25 July 2025
Hey! We are Nemo.
Nemo, short for Never Miss Out, is a mobile investment platform that delivers curated, data-driven investment ideas to your fingertips. It offers commission-free trading across stocks, ETFs, crypto, and CFDs, along with AI-powered tools, real-time market alerts, and themed stock collections called Nemes.
Download the App
Scan the QR code to download the Nemo app and start investing on Nemo today
published-on
Read article
published-on
Read article
published-on
Read article
published-on
Read article
published-on
Read article
View the full Basket:Rest & Recovery
I remember a time when bragging about how little sleep you got was a badge of honour. It was a sign of hustle, of grit, of being too important for something as mundane as rest. How utterly foolish we were. Today, the tables have turned completely. The new status symbol isn’t a flashy watch or a fast car, it’s boasting about your eight hours of uninterrupted, deep REM sleep, tracked meticulously on a device that costs more than my first car did. This isn't just a cultural quirk, it's a seismic economic shift.
View the full Basket:Rest & Recovery
What was once considered dead time is now the ultimate performance enhancer, and where there’s performance, there’s profit. The so called sleep economy is now a multi billion dollar industry, built on our collective anxiety that we’re not resting correctly. It’s a brilliant business model, really. It taps into a universal need and then sells us a thousand ways to optimise it. From weighted blankets and blackout curtains to white noise machines that sound like a gentle Patagonian breeze, we’ve become obsessed. And I think this obsession has legs. Unlike fleeting wellness fads, the fundamental need for sleep isn’t going anywhere.
View the full Basket:Rest & Recovery
Beyond the lifestyle fluff, there's a much more serious, and to me, more interesting, side to this market. We’re talking about the medical treatment of sleep disorders. Millions of people suffer from conditions like sleep apnea, a problem that goes far beyond simple snoring. It’s a serious health issue, and companies solving it are not just selling a good night's sleep, they are selling a longer, healthier life. Take a company like ResMed, a giant in treating sleep disordered breathing. Or look at Inspire Medical Systems, which is developing clever neurostimulation technology for patients who can’t tolerate traditional machines. These aren't faddish wellness products, they are critical medical devices addressing a vast and underserved market. That, to an investor, should sound like a very appealing proposition.
View the full Basket:Rest & Recovery
Of course, the consumer technology side is where things get flashy. Companies like Sleep Number have transformed the humble mattress into a data harvesting, climate controlling wellness hub. It’s this convergence of medical need and consumer desire that makes the whole sector so compelling. You have everything from high tech medical devices to smart pillows, all bundled under one big, comfortable duvet. It’s why a focused theme like the Rest & Recovery Stocks might capture the attention of those looking at the bigger picture of modern health. This isn't just about comfort, it's about data. We love data. It gives us a sense of control, a feeling that we can biohack our way to a better self, one sleep cycle at a time.
View the full Basket:Rest & Recovery
Now, let’s not get carried away and start dreaming of guaranteed returns. Investing in any emerging sector comes with its own set of nightmares. The medical device field is a minefield of regulatory hurdles and lengthy approval processes. On the consumer side, competition is fierce. For every brilliant idea, there are a dozen copycats, and a big tech giant could always decide to enter the market and throw its weight around. Valuations for some of these companies are already priced for perfection, meaning any stumble could lead to a rude awakening for shareholders. As with any investment, there are risks, and a healthy dose of scepticism is always your best friend.
View the full Basket:Rest & Recovery
View the full Basket:Rest & Recovery
View the full Basket:Rest & Recovery
View the full Basket:Rest & Recovery
View the full Basket:Rest & Recovery
View the full Basket:Rest & Recovery
This article is marketing material and should not be construed as investment advice. No information set out in this article be considered, as advice, recommendation, offer, or a solicitation, to buy or sell any financial product, nor is it financial, investment, or trading advice. Any references to specific financial product or investment strategy are for illustrative / educational purposes only and subject to change without notice. It is the investor’s responsibility to evaluate any prospective investment, assess their own financial situation, and seek independent professional advice. Past performance is not indicative of future results. Please refer to our Risk Disclosure.
published-on
Read article
published-on
Read article
published-on
Read article
published-on
Read article
published-on
Read article